Pesquisas alternativas:
after last » after blast (Expandir a Pesquisa), after laser (Expandir a Pesquisa), after lasik (Expandir a Pesquisa)
last phase » blast phase (Expandir a Pesquisa), yeast phase (Expandir a Pesquisa), gait phase (Expandir a Pesquisa)
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa)
after last » after blast (Expandir a Pesquisa), after laser (Expandir a Pesquisa), after lasik (Expandir a Pesquisa)
last phase » blast phase (Expandir a Pesquisa), yeast phase (Expandir a Pesquisa), gait phase (Expandir a Pesquisa)
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa)
41
Por Omosa-Manyonyi, Gloria, Mpendo, Juliet, Ruzagira, Eugene, Kilembe, William, Chomba, Elwyn, Roman, François, Bourguignon, Patricia, Koutsoukos, Marguerite, Collard, Alix, Voss, Gerald, Laufer, Dagna, Stevens, Gwynn, Hayes, Peter, Clark, Lorna, Cormier, Emmanuel, Dally, Len, Barin, Burc, Ackland, Jim, Syvertsen, Kristen, Zachariah, Devika, Anas, Kamaal, Sayeed, Eddy, Lombardo, Angela, Gilmour, Jill, Cox, Josephine, Fast, Patricia, Priddy, Frances
Publicado no PLoS One (2015)
“... persisted at least a year after the last vaccination. The complementary response profiles, characteristic...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
42
Por Merkies, Ingemar S.J., van Schaik, Ivo N., Léger, Jean‐Marc, Bril, Vera, van Geloven, Nan, Hartung, Hans‐Peter, Lewis, Richard A., Sobue, Gen, Lawo, John‐Philip, Durn, Billie L., Cornblath, David R., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Tackenberg, Björn, Mielke, Orell
Publicado no J Peripher Nerv Syst (2019)
“... March 2019 after first online publication: the INCAT response rate has been corrected.]....”Publicado no J Peripher Nerv Syst (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
43
Por Weber, Jeffrey S., Kudchadkar, Ragini Reiney, Yu, Bin, Gallenstein, Donna, Horak, Christine E., Inzunza, H. David, Zhao, Xiuhua, Martinez, Alberto J., Wang, Wenshi, Gibney, Geoffrey, Kroeger, Jodi, Eysmans, Cabell, Sarnaik, Amod A., Chen, Y. Ann
Publicado em 2013
“... death-1 checkpoint protein, has activity against metastatic melanoma. Its safety, clinical efficacy...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
44
663. Efficacy and Safety of Lefamulin (LEF) vs. Moxifloxacin (MOX) for Legionella pneumophila (LP...
Por Shorr, Andrew F, Schranz, Jennifer, Goldberg, Lisa, Paukner, Susanne, Das, Anita F, Moran, Gregory J, Sandrock, Christian, File, Thomas M, Alexander, Elizabeth, Gelone, Steven P
Publicado no Open Forum Infect Dis (2019)
“...; 5–10 days after last dose) in the modified ITT (received ≥1 dose) and clinically evaluable (met...”Publicado no Open Forum Infect Dis (2019)
Obter o texto integral
Obter o texto integral
Artigo
45
Por Lopez-Medina, Eduardo, Melgar, Mario, Gaensbauer, James T., Bandyopadhyay, Ananda S., Borate, Bhavesh R., Weldon, William C., Rüttimann, Ricardo, Ward, Joel, Clemens, Ralf, Asturias, Edwin J.
Publicado no Vaccine (2017)
“... and IME) were monitored for 6 months after last study vaccine. RESULTS: At week 18, 4 weeks after one dose...”Publicado no Vaccine (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
46
Por Chung, Moon Jae, Kang, Huapyong, Kim, Ho Gak, Hyun, Jong Jin, Lee, Jun Kyu, Lee, Kwang Hyuck, Noh, Myung Hwan, Kang, Dae Hwan, Lee, Sang Hyub, Bang, Seungmin
Publicado no World J Gastrointest Oncol (2018)
“... according to the phase I study of FOLFIRINOX. The objective response rate (ORR), disease control rate (DCR...”Publicado no World J Gastrointest Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
47
Por de Sousa Fernandes Perna, Elizabeth B., Theunissen, Eef L., Dolder, Patrick C., Mason, Natasha L., Hutten, Nadia R. P. W., Toennes, Stefan W., Kuypers, Kim P. C., Ramaekers, Johannes G.
Publicado no Front Pharmacol (2018)
“... after administration that was followed by a sustained increase in heart rate. After an interim review...”Publicado no Front Pharmacol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
48
Por Beran, Jirí, Hobzova, Lenka, Wertzova, Veronika, Kuriyakose, Sherine, Leyssen, Maarten, Surquin, Murielle, Houard, Sophie
Publicado em 2010
“... the last vaccine dose. Lot-to-lot consistency was established. High seroprotection rates were already...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
49
Por Hyland, Elizabeth, Mant, Tim, Vlachos, Pantelis, Attkins, Neil, Ullmann, Martin, Roy, Sanjeev, Wagner, Volker
Publicado no Br J Clin Pharmacol (2016)
“...AIMS: The aim of the study was to compare the pharmacokinetics (PK), safety and tolerability...”Publicado no Br J Clin Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
50
Por Maruyama, Dai, Tsukasaki, Kunihiro, Uchida, Toshiki, Maeda, Yoshinobu, Shibayama, Hirohiko, Nagai, Hirokazu, Kurosawa, Mitsutoshi, Suehiro, Yoko, Hatake, Kiyohiko, Ando, Kiyoshi, Yoshida, Isao, Hidaka, Michihiro, Murayama, Tohru, Okitsu, Yoko, Tsukamoto, Norifumi, Taniwaki, Masafumi, Suzumiya, Junji, Tamura, Kazuo, Yamauchi, Takahiro, Ueda, Ryuzo, Tobinai, Kensei
Publicado no Ann Hematol (2018)
“... and safety of forodesine, a novel purine nucleoside phosphorylase inhibitor, in patients with relapsed...”Publicado no Ann Hematol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
51
Por Tarhini, Ahmad A., Cherian, John, Moschos, Stergios J., Tawbi, Hussein A., Shuai, Yongli, Gooding, William E., Sander, Cindy, Kirkwood, John M.
Publicado em 2012
“... to significant and durable clinical responses. PATIENTS AND METHODS: We conducted a phase II study in which...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
52
Por Flinn, Ian W., Gribben, John G., Dyer, Martin J. S., Wierda, William, Maris, Michael B., Furman, Richard R., Hillmen, Peter, Rogers, Kerry A., Iyer, Swaminathan Padmanabhan, Quillet-Mary, Anne, Ysebaert, Loic, Walter, Harriet S., Verdugo, Maria, Klein, Christian, Huang, Huang, Jiang, Yanwen, Lozanski, Gerard, Pignataro, Daniela Soriano, Humphrey, Kathryn, Mobasher, Mehrdad, Kipps, Thomas J.
Publicado no Blood (2019)
“..., respectively, was 64% and 91% ≥3 months after last obinutuzumab dose. Venetoclax and obinutuzumab therapy had...”Publicado no Blood (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
53
Por Wessels, Alette M., Tariot, Pierre N., Zimmer, Jennifer A., Selzler, Katherine J., Bragg, Sonja M., Andersen, Scott W., Landry, John, Krull, James H., Downing, AnnCatherine M., Willis, Brian A., Shcherbinin, Sergey, Mullen, Jamie, Barker, Peter, Schumi, Jennifer, Shering, Craig, Matthews, Brandy R., Stern, Robert A., Vellas, Bruno, Cohen, Sharon, MacSweeney, Emer, Boada, Mercè, Sims, John R.
Publicado no JAMA Neurol (2020)
“... dementia. DESIGN, SETTING, AND PARTICIPANTS: AMARANTH (first patient visit on September 30, 2014; last...”Publicado no JAMA Neurol (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
54
Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy...
Por Yun Guan, Jing Li, Xiu Gong, Huaguang Zhu, Chao Li, Guanghai Mei, Xiaoxia Liu, Li Pan, Jiazhong Dai, Yang Wang, Enmin Wang, Ying Liu, Xin Wang
Publicado em 2022-04-01
“... was administered d1-14 every 3 weeks. The primary endpoint was the objective response rate (ORR). Secondary...”Publicado em 2022-04-01
Obter o texto integral
Artigo
55
Por Becker, Andreas, Martin, Emily C., Mitchell, David Y., Grenningloh, Roland, Bender, Andrew T., Laurent, Julien, Mackenzie, Harald, Johne, Andreas
Publicado no Clin Transl Sci (2019)
“... after single doses ≥ 200 mg; the effect was long‐lasting (> 50% occupancy at 96 hours with ≥ 100 mg...”Publicado no Clin Transl Sci (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
56
Por Pliszka, Steven R., Wilens, Timothy E., Bostrom, Samantha, Arnold, Valerie K., Marraffino, Andrea, Cutler, Andrew J., López, Frank A., DeSousa, Norberto J., Sallee, Floyd R., Incledon, Bev, Newcorn, Jeffrey H.
Publicado no J Child Adolesc Psychopharmacol (2017)
“.... This phase 3 study evaluated the safety and efficacy of DR/ER-MPH on symptoms and temporal at-home functional...”Publicado no J Child Adolesc Psychopharmacol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
57
Por Hijiya, Nobuko, Thomson, Blythe, Isakoff, Michael S., Silverman, Lewis B., Steinherz, Peter G., Borowitz, Michael J., Kadota, Richard, Cooper, Todd, Shen, Violet, Dahl, Gary, Thottassery, Jaideep V., Jeha, Sima, Maloney, Kelly, Paul, Jo-Anne, Barry, Elly, Carroll, William L., Gaynon, Paul S.
Publicado em 2011
“... ALL was evaluated in this phase 2 study. The primary endpoint was overall response rate (complete...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
58
Por Sundar, Shyam, Singh, Anup, Rai, Madhukar, Chakravarty, Jaya
Publicado no Am J Trop Med Hyg (2015)
“... of long-lasting cure rate. Thirty men and thirty women between 12 and 60 years old with parasitologically...”Publicado no Am J Trop Med Hyg (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
59
Por Kim, Richard, Chiorean, E Gabriela, Amin, Manik, Rocha-Lima, Caio Max S, Gandhi, Jitendra, Harris, William P, Song, Tao, Portnoy, David
Publicado no Br J Cancer (2017)
“...BACKGROUND: This multicentre, open-label study evaluated the efficacy and safety of SPI-1620...”Publicado no Br J Cancer (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
60
Por McDermott, David F., Drake, Charles G., Sznol, Mario, Choueiri, Toni K., Powderly, John D., Smith, David C., Brahmer, Julie R., Carvajal, Richard D., Hammers, Hans J., Puzanov, Igor, Hodi, F. Stephen, Kluger, Harriet M., Topalian, Suzanne L., Pardoll, Drew M., Wigginton, Jon M., Kollia, Georgia D., Gupta, Ashok, McDonald, Dan, Sankar, Vindira, Sosman, Jeffrey A., Atkins, Michael B.
Publicado no J Clin Oncol (2015)
“... with advanced treatment-refractory solid tumors. We report clinical activity, survival, and long-term safety...”Publicado no J Clin Oncol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo